{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:41:49Z","timestamp":1790764909258,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.det.2023.08.005","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:02:26Z","timestamp":1694646146000},"page":"285-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neutrophilic Panniculitides"],"prefix":"10.1016","volume":"42","author":[{"given":"Ganesh B.","family":"Maniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Coakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giang","family":"Huong Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.det.2023.08.005_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/DAD.0000000000001597","article-title":"Neutrophilic infiltrates in panniculitis: comprehensive review and diagnostic algorithm proposal","volume":"42","author":"Llamas-Velasco","year":"2020","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.det.2023.08.005_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ijd.15224","article-title":"Ulcerative versus non-ulcerative panniculitis: is it time for a novel clinical approach to panniculitis?","volume":"60","author":"Shavit","year":"2021","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.08.005_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40257-022-00709-9","article-title":"Suggestions for a new clinical classification approach to panniculitis based on a Mayo Clinic experience of 207 Cases","volume":"23","author":"Anand","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.det.2023.08.005_bib4","first-page":"2611","article-title":"Cutaneous manifestations in pancreatic diseases - a review","volume":"9","author":"Miulescu","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.det.2023.08.005_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2021.01.074","article-title":"Alpha-1 antitrypsin deficiency\u2013associated panniculitis","volume":"87","author":"Franciosi","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.08.005_bib6","unstructured":"A study to evaluate safety, tolerability and pharmacokinetics of two different doses of alpha1-proteinase inhibitor subcutaneous (human) 15% in participants with alpha1-antitrypsin deficiency. ClinicalTrials.gov identifier: NCT04722887. Updated February 27, 2023 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04722887. Accessed June 14, 2023."},{"key":"10.1016\/j.det.2023.08.005_bib7","unstructured":"A study of ARC-AAT in healthy volunteer subjects and patients with alpha-1 antitrypsin deficiency (AATD). ClinicalTrials.gov identifier: NCT02363946. Updated August 3, 2018 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02363946. Accessed June 14, 2023."},{"key":"10.1016\/j.det.2023.08.005_bib8","unstructured":"Evaluate efficacy and safety of \"Kamada-AAT for inhalation\" in patients with AATD (InnovAATe). ClinicalTrials.gov identifier: NCT04204252. Updated May 3, 2023 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04204252. Accessed June 14, 2023."},{"key":"10.1016\/j.det.2023.08.005_bib9","unstructured":"Phase 1 study to assess the safety, PK, and PD of INBRX-101 in adults with alpha-1 antitrypsin deficiency (rhAAT-Fc). ClinicalTrials.gov identifier: NCT03815396. Updated September 13, 2022 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03815396. Accessed June 14, 2023."},{"key":"10.1016\/j.det.2023.08.005_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1179547620917958","article-title":"Pfeifer-Weber-Christian disease: A case report and review of literature on visceral involvements and treatment choices","volume":"13","author":"Rotondo","year":"2020","journal-title":"Clin Med Insights Case Rep"},{"issue":"12","key":"10.1016\/j.det.2023.08.005_bib11","first-page":"447","article-title":"Recognizing Weber-Christian disease","volume":"89","author":"Khan","year":"1996","journal-title":"Tenn Med"},{"key":"10.1016\/j.det.2023.08.005_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1529-8019.2010.01333.x","article-title":"Infection and panniculitis","volume":"23","author":"Morrison","year":"2010","journal-title":"Dermatolog Ther"},{"issue":"4","key":"10.1016\/j.det.2023.08.005_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.det.2008.05.005","article-title":"Infective panniculitis","volume":"26","author":"Delgado-Jiminez","year":"2008","journal-title":"Dermatol Clin"},{"issue":"6","key":"10.1016\/j.det.2023.08.005_bib14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jaad.2012.12.954","article-title":"Subcutaneous Sweet syndrome in the setting of myeloid disorders: A case series and review of the literature","volume":"68","author":"Chan","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.08.005_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.clindermatol.2020.06.012","article-title":"Neutrophilic drug reactions","volume":"38","author":"Coromilas","year":"2020","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.08.005_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1440-0960.1983.tb00252.x","article-title":"Review of so-called aseptic neutrophilic dermatoses","volume":"24","author":"Moschella","year":"1983","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2023.08.005_bib17","doi-asserted-by":"crossref","unstructured":"Heath MS, Ortega-Loayza AG. Insights into the pathogenesis of Sweet's syndrome. Front Immunol. 2019; 10. Available at: https:\/\/doi.org\/10.3389\/fimmu.2019.00414. Accessed June 15, 2023.","DOI":"10.3389\/fimmu.2019.00414"},{"key":"10.1016\/j.det.2023.08.005_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bjd.14606","article-title":"Neutrophilic panniculitis and autoinflammation: what's the link? [letter to the editor]","volume":"175","author":"Marzano","year":"2016","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.08.005_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00000372-199906000-00007","article-title":"Neutrophilic lobular (pustular) panniculitis associated with rheumatoid arthritis: a case report and review of the literature","volume":"21","author":"Tran","year":"1999","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.det.2023.08.005_bib20","doi-asserted-by":"crossref","first-page":"100176","DOI":"10.1016\/j.xjidi.2022.100176","article-title":"Dermatologic manifestations of noninflammasome-mediated autoinflammatory diseases","volume":"3","author":"Symmank","year":"2023","journal-title":"JID Innovations"},{"issue":"27","key":"10.1016\/j.det.2023.08.005_bib21","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.det.2023.08.005_bib22","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2022016985","article-title":"Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis","volume":"140","author":"Ferrada","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.det.2023.08.005_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.seminhematol.2021.10.005","article-title":"VEXAS syndrome: an inflammatory and hematologic disease","volume":"58","author":"Patel","year":"2021","journal-title":"Semin Hematol"},{"key":"10.1016\/j.det.2023.08.005_bib24","unstructured":"Ferrada M. VEXAS syndrome. NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases. Updated April 2023. Available at: https:\/\/www.niams.nih.gov\/labs\/grayson-lab\/vexas. Accessed June 15, 2023."},{"issue":"26","key":"10.1016\/j.det.2023.08.005_bib25","first-page":"3591","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.det.2023.08.005_bib26","doi-asserted-by":"crossref","unstructured":"Gutierrez-Rodrigues F, Kusne Y, Fernandez J, et\u00a0al. Spectrum of clonal hematopoiesis in VEXAS syndrome. Blood. 2023. Available at: https:\/\/doi.org\/10.1182\/blood.2022018774. Accessed June 15, 2023.","DOI":"10.1182\/blood.2022018774"},{"key":"10.1016\/j.det.2023.08.005_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nm.4474","article-title":"A\u00a0small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment","volume":"24","author":"Hyer","year":"2018","journal-title":"Nat Med"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386352300075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386352300075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:47:22Z","timestamp":1760006842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386352300075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S073386352300075X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2023.08.005","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophilic Panniculitides","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2023.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}